NASDAQ : GUTS
Fractyl Health, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 0.9765 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 12.95M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 12.95M |
| Enterprise Value | 26.55M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 13.26M |
| Shares Outstanding | 13.26M |
| Shares Change (YoY) | +168.74% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | 1.36% |
| Owned by Institutions (%) | 43.64% |
| Float | 12.14M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.15 |
| Quick Ratio | 3.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -74.57% |
| Return on Invested Capital (ROIC) | -104.67% |
| Return on Capital Employed (ROCE) | -129.67% |
| Weighted Average Cost of Capital (WACC) | 3.08% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.06M |
| Employee Count | 100 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.42 |
| 52-Week Price Change | -93.49% |
| 50-Day Moving Average | 5.46 |
| 200-Day Moving Average | 7.88 |
| Relative Strength Index (RSI) | 17.02 |
| Average Volume (20 Days) | 1,183,317 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 265,311 |
| Short Previous Month | 2.15M |
| Short % of Shares Out | 2.00% |
| Short % of Float | 2.18% |
| Short Ratio (days to cover) | 1.44 |
Incomestatement
| Measure | Value |
|---|
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -85.89M |
| Pretax Income | -105.65M |
| Net Income | -105.65M |
| EBITDA | -84.77M |
| EBIT | -85.89M |
| Earnings Per Share (EPS) | -$9.71 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 47.14M |
| Total Debt | 60.74M |
| Net Cash | -13.60M |
| Net Cash Per Share | -$1.02 |
| Equity (Book Value) | -1.67M |
| Book Value Per Share | -0.13 |
| Working Capital | 33.87M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -82.43M |
| Capital Expenditures | -11,000 |
| Depreciation & Amortization | 1.13M |
| Net Borrowing | -486,000 |
| Free Cash Flow | -82.44M |
| FCF Per Share | -$6.21 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -168.74% |
| Shareholder Yield | -168.74% |
| Earnings Yield | -993.89% |
| FCF Yield | -636.43% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $36.80 |
| Price Target Difference | 3,668.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 5, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |